Our team of experts brings you cancer-related news and research updates.
Put health on your back-to-school planning list this year. Vaccinations, nutritious lunches, and sleeping right are all part of the equation.
The latest statistics about the major cancer risk factors and screening test use in the United States are now available in the journal Cancer Epidemiology, Biomarkers & Prevention and in the American Cancer Society Report Cancer Prevention and Early Detection, 2021-2022.
Only about 30% of adolescents who live in rural Oregon are up to date with the HPV vaccine. Learn how the RAVE Study is helping uncover vaccine barriers & solutions.
A study using data from the Centers for Disease Control and Prevention (CDC) provides evidence that the human papillomavirus (HPV) vaccine is effectively reducing the numbers of cervical precancer – lesions that can become cervical cancer.
Back-to-school time is a good time to find out what vaccinations are recommended for everyone – young, old, and in-between – especially this year when many routine care visits have been delayed.
The American Cancer Society (ACS) has updated its guideline for human papilloma virus (HPV) vaccination. New recommendations are for healthcare providers to routinely offer the HPV vaccine series to boys and girls between ages 9 and 12.
To help both the death and diagnosis rates of colorectal cancer drop—and to help those who develop it survive and thrive—the American Cancer Society (ACS) funds the research of scientists across the country who use the latest evidence and cutting-edge technology to help prevent and treat CRC. Here are two of their stories.
The US Centers for Disease Control and Prevention (CDC) reports that just over half (51.1%) of teenagers were fully vaccinated for human papillomavirus (HPV) as of 2018, up 2.5 percentage points from 48.6% in 2017.